<DOC>
<DOCNO>1050701_business_story_4936532.utf8</DOCNO>
<TEXT>


The Telegraph - Calcutta : Business

 Ranbaxy pops stock-split pill

 OUR SPECIAL CORRESPONDENT 

 Mumbai, June 30: Ranbaxy Laboratories Ltd will sub-divide its shares to a face value of Rs 5 per scrip from Rs 10.

 The companys shareholders today approved the stock split at the annual general meeting. On the BSE, the Ranbaxy scrip shot up to an intra-day high of Rs 1,082.10 after opening at Rs 1,075. The scrip closed at Rs 1057.65.

 A stock split benefits the retail shareholder ? not only does the liquidity of a scrip improve but also makes it more affordable.

 In recent times, ITC Ltd, Sun Pharmaceuticals (India) Ltd, Dr Reddys Laboratories Ltd, Sundaram Fasteners, Bharat Forge have announced stock splits. 

 Recently, ITC Ltd had recommended the sub-division of shares in 1:10 ratio (one ordinary share of the face value of Rs 10 into 10 shares of Re 1 each), subject to shareholders approval.

 Earlier, Pune-based Bharat Forge had approved sub-dividing its shares to a face value of Rs 2 per scrip from Rs 10. 

 Even the government is planning a stock-split in some state-run companies. Recent reports have said the government is considering a stock split in state-run Shipping Corporation of India ahead of a proposed 15 per cent equity sale.




</TEXT>
</DOC>